Report : Asia Pacific Antacids Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Dosage Form (Tablet, Liquid, and Others); Drug Class (Proton Pump Inhibitors, H2 Antagonist, and Acid Neutralizers); Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy)
According to a new market research study of ‘Asia Pacific Antacids Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by dosage form, drug class, and distribution channel’ the Asia Pacific Antacids market is expected to reach US$ 3,255.05 million in 2027 from US$ 2,287.19 million in 2019. The market is estimated to grow with a CAGR of 4.6% from 2020-2027. The report provides trends prevailing in the Asia Pacific Antacids market and the factors driving market along with those that act as hindrances.
Based on the dosage form, the antacids market is segmented into tablet, liquid, and others. The tablet segment held the largest share of the market, whereas the liquid segment is expected to register the highest CAGR during the forecast period. The tablet segment’s market growth is expected due to the availability of different types of antacid tablets, easy storage and accurate dosage, the segment is likely to favor the growth of antacid market. The liquid segment is anticipated to register the highest CAGR in the market during the forecast period. The growth of the segment is attributed to growing preference by children and ageing population due to its flavored/palatable taste. Also, presence of major market players such as Procter & Gamble, Pfizer, GSK GROUP and others are offering liquid antacids which is likely to propel the growth of the segment.
The growth of this market is estimated to grow owing to key driving factors such as the increasing innovative product launches by market players and the higher incidence of the obese population. However, the market is expected experiencing slow growth during the forecast period owing to the stringent regulatory norms and several challenges associated with gastrointestinal diseases.
Bayer AG, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Sun Pharmaceutical Industries Ltd, Sanofi, Boehringer Ingelheim International GmbH, Dr. Reddy's Laboratories, Pfizer Inc, Reckitt Benckiser Group Plc, Procter & Gamble are among the leading companies operating in the Asia Pacific Antacids market.
The report segments Asia Pacific Antacids Market as Follows:
By Dosage Form
- Tablet
- Liquid
- Others
By Drug Class
- Proton Pump Inhibitors
- H2 Antagonist
- Acid Neutralizers
- Magaldrate
- Sucralfate
- Others
By Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
By Country
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@businessmarketinsights.com